Does RISANKIZUMAB-RZAA Cause Transient ischaemic attack? 144 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 144 reports of Transient ischaemic attack have been filed in association with RISANKIZUMAB-RZAA. This represents 0.2% of all adverse event reports for RISANKIZUMAB-RZAA.
144
Reports of Transient ischaemic attack with RISANKIZUMAB-RZAA
0.2%
of all RISANKIZUMAB-RZAA reports
1
Deaths
80
Hospitalizations
How Dangerous Is Transient ischaemic attack From RISANKIZUMAB-RZAA?
Of the 144 reports, 1 (0.7%) resulted in death, 80 (55.6%) required hospitalization, and 1 (0.7%) were considered life-threatening.
Is Transient ischaemic attack Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 144 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Transient ischaemic attack?
APIXABAN (1,157)
RIVAROXABAN (820)
LENALIDOMIDE (655)
ADALIMUMAB (604)
ASPIRIN (587)
ROSIGLITAZONE (585)
NAPROXEN (521)
LEVOTHYROXINE (517)
DABIGATRAN ETEXILATE (471)
CLOPIDOGREL BISULFATE (454)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Transient ischaemic attack Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA